Gene: Sdha
Official Full Name: succinate dehydrogenase complex, subunit A, flavoprotein (Fp)provided by MGI
Gene Summary: Predicted to enable electron transfer activity; flavin adenine dinucleotide binding activity; and succinate dehydrogenase (quinone) activity. Predicted to contribute to succinate dehydrogenase activity. Predicted to be involved in mitochondrial electron transport, succinate to ubiquinone; nervous system development; and succinate metabolic process. Located in mitochondrial inner membrane and myelin sheath. Part of respiratory chain complex II (succinate dehydrogenase). Is active in mitochondrion. Is expressed in several structures, including alimentary system; brain; genitourinary system; hemolymphoid system; and sensory organ. Human ortholog(s) of this gene implicated in Leigh disease; dilated cardiomyopathy 1GG; lung non-small cell carcinoma; mitochondrial complex II deficiency; and paraganglioma. Orthologous to human SDHA (succinate dehydrogenase complex flavoprotein subunit A). [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01151 | Sdha Knockout cell line(RAW 264.7) | Mouse | Sdha | 1:2-1:3 | Negative | Online Inquiry |
Sdha gene knockout cell lines are genetically engineered cell lines in which the succinate dehydrogenase A (SDHA) gene has been disrupted, rendering the cells deficient in this critical enzyme. Succinate dehydrogenase is a key component of both the citric acid cycle and the electron transport chain, underscoring its essential role in cellular respiration and energy production. By utilizing Sdha gene knockout cell lines, researchers can study the biological consequences of SDHA deficiency, such as impaired mitochondrial function and altered metabolic profiles.
These cell lines function as a powerful tool for understanding metabolic disorders linked to mitochondrial dysfunction and have significant implications in cancer research, as SDHA mutations are frequently implicated in various tumors. The knockout model allows for comprehensive studies into the mechanistic pathways influenced by succinate accumulation and reactive oxygen species production, enabling scientists to explore novel therapeutic approaches targeting these metabolic pathways.
The scientific importance of Sdha gene knockout cell lines extends to their utility in drug discovery and development, as they provide a platform for screening compounds that may restore normal metabolic function or target the altered pathways in cancer cells. Compared to other models, such as transient knockdowns or overexpression systems, these stable knockout cell lines offer consistent gene editing results, increased reproducibility, and a more straightforward approach for longitudinal studies.
For researchers and clinicians, Sdha gene knockout cell lines represent an invaluable resource that not only enhances experimental rigor but also facilitates a deeper understanding of mitochondrial biology. Our company specializes in providing high-quality genetic models tailored to meet the rigorous demands of contemporary research. With a commitment to excellence and ongoing support, we empower our customers to drive discoveries that can translate into impactful advancements in both academia and clinical practice.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.